Seretide Disckus (Advair) at a Glance
Seretide Diskus is a combination pharmaceutical preparation containing fluticasone propionate (corticosteroid) and salmeterol xinafoate (long-acting beta2-agonist) formulated for respiratory research applications. This dual-component formulation enables comprehensive investigation of anti-inflammatory and bronchodilatory mechanisms in laboratory studies. Researchers at Stroid UK Shop utilise this preparation to examine corticosteroid-beta2 agonist synergistic pathways in respiratory cell culture models and tissue preparations.
Laboratory Applications
This preparation facilitates examination of glucocorticoid receptor binding and subsequent gene transcription modulation alongside beta2-adrenergic receptor activation studies. Research scientists investigate the dual mechanism whereby fluticasone propionate suppresses inflammatory cytokine production while salmeterol activates adenylyl cyclase pathways. Studies focus on evaluating anti-inflammatory cascades, examining bronchial smooth muscle relaxation pathways, and analysing corticosteroid-mediated protein synthesis inhibition. Respiratory research laboratories examine this combination for investigating asthma pathophysiology models and chronic obstructive pulmonary disease mechanisms. Comparative analyses with other pharmaceutical preparations provide comprehensive research data on combination therapy mechanisms.
Technical Specifications
| Active Components | Fluticasone propionate 250 mcg + Salmeterol xinafoate 25 mcg |
|---|---|
| Formulation | Dry powder inhaler preparation |
| Manufacturer | GlaxoSmithKline |
| Research Applications | Respiratory pathway studies, anti-inflammatory mechanism research |
| Storage Requirements | Room temperature, dry conditions, protect from moisture |
| Batch Documentation | Certificate of analysis available |
Advanced research facilities studying respiratory pharmacology often incorporate this preparation alongside selective receptor modulators and bioactive peptides for comprehensive respiratory system investigations.
Research Compliance
This Seretide Diskus preparation is supplied exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any clinical applications. Researchers must maintain appropriate laboratory protocols and safety procedures when handling this preparation. All studies should comply with institutional research guidelines and applicable laboratory safety regulations.
